TW

Timothy Weeden

DT Dyne Therapeutics: 2 patents #1 of 3Top 35%
GE Genzyme: 2 patents #8 of 122Top 7%
Overall (2021): #38,580 of 548,734Top 8%
4
Patents 2021

Issued Patents 2021

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11168141 Muscle targeting complexes and uses thereof for treating dystrophinopathies Romesh R. Subramanian, Mohammed T. Qatanani 2021-11-09
11116755 Biomarker of polycystic kidney disease and uses thereof Sarah Moreno, Nikolai Bukanov 2021-09-14
11111309 Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4 Romesh R. Subramanian, Mohammed T. Qatanani 2021-09-07
11103587 Multiple oligonucleotide moieties on peptide carrier Carol A. Nelson, Bruce M. Wentworth, Nicholas P. CLAYTON, Andrew Leger 2021-08-31